CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2026	Mar. 31, 2025
Operating Activities:
Net Income		$ 8,706	$ 13,742
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses		1,594	301
Depreciation		1,493	1,133
Amortization of intangibles		1,300	428
Net amortization of security discounts/premiums		229	70
Noncash operating lease expense		795	619
Amortization of finance lease right-of-use asset		45	45
Earnings on cash surrender value of life insurance		(705)	(274)
Mortgage loans originated for sale		(21,039)	(20,566)
Proceeds from sales of mortgage loans originated for sale		8,467	21,370
Gain on sale of mortgage loans		(314)	(591)
SBA loans originated for sale		(2,783)	(728)
Proceeds from sales of SBA loans originated for sale		2,948	785
Gain on sale of SBA loans		(163)	(57)
Loss/(gain) on sale or write-down of foreclosed assets		491	(28)
Discount on subordinated debt		0	(154)
Accretion of loan fair value marks		2,441	989
Restricted stock compensation expense		533	218
Stock option expense		132	0
Deferred income tax expense		1,309	206
Increase/(decrease) in accrued interest receivable		740	(417)
Increase in other assets		867	822
Increase/(decrease) in accrued interest payable		1,125	(584)
Increase/(decrease) in operating lease liability		1,700	(649)
Increase/(decrease) in other liabilities		4,544	(4,162)
Net Cash Provided By Operating Activities		14,455	12,518
Investing Activities:
Proceeds from the maturity or call of available-for-sale securities		28,265	6,609
Purchases of available-for-sale securities		(98,899)	0
Proceeds from the maturity or call of held-to-maturity securities		6,342	7,265
Redemption of restricted investment in bank stock		13,023	7,693
Purchases of restricted investment in bank stock		(15,528)	(6,892)
Net cash received from acquisitions		162,808	0
Net increase in loans		(65,628)	(50,465)
Purchases of bank premises and equipment		(1,425)	(2,720)
Proceeds from the sale of premises and equipment		0	65
Proceeds from the sale of foreclosed assets		168	72
Proceeds from bank-owned life insurance		2,022	527
Earnings on bank-owned life insurance		0	(83)
Net change in investments in tax credits and other partnerships		2,770	647
Net Cash Provided by (Used in) Investing Activities		33,918	(37,282)
Financing Activities:
Net increase in deposits		9,393	42,275
Common stock dividends paid		(6,237)	(3,870)
Proceeds from Employee and Director Stock Purchase Plan stock issuance		194	163
Net change in finance lease liability		(37)	(36)
Proceeds from short-term borrowings		453,300	25,000
Repayment of short-term borrowings		(442,633)	(2,000)
Long-term debt repayment		(20,081)	(78)
Net Cash (Used in)/Provided by Financing Activities		(6,101)	61,454
Net increase in cash and cash equivalents		42,272	36,690
Cash and cash equivalents, beginning of period		98,918	70,564
Cash and cash equivalents, end of period		141,190	107,254
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest		27,424	29,819
Cash paid for income taxes		0	185
Supplemental Noncash Disclosures:
Recognition of operating lease right-of-use assets		81	2,322
Recognition of operating lease liabilities		81	2,322
Loans transferred to foreclosed assets held-for-sale		1,273	1,402
Common Stock issued to Cumberland Advisors and 1st Colonial Shareholders		2,238	0
Fair value of assets acquired in business combinations, excluding cash	[1]	756,794	0
Goodwill recorded	[1]	20,391	0
Liabilities assumed in business combination	[1]	753,509	0
Fair value of common stock issued	[1]	$ 71,853	$ 0

[1] Includes the impact of the 1st Colonial acquisition on February 27, 2026 and the Cumberland Advisors acquisition on January 1, 2026. See "Note 2 - Business Combinations" to the Consolidated Financial Statements for more information.